These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8697670)

  • 1. A decade of research on the natural history of HIV infection: Part 1. Markers.
    Strathdee SA; O'Shaughnessy MV; Montaner JS; Schechter MT
    Clin Invest Med; 1996 Apr; 19(2):111-20. PubMed ID: 8697670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
    Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
    Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing HIV. Part 4: Primary therapy. 4.3 The laboratory in managing HIV infection.
    Dwyer DE; Adelstein S; Cunningham AL; Merigan TC
    Med J Aust; 1996 Mar; 164(5):301-3. PubMed ID: 8628167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-2-microglobulin, neopterin and monocyte Fc gamma receptors in opportunistic infections of HIV-positive patients.
    Dunne J; Feighery C; Whelan A
    Br J Biomed Sci; 1996 Dec; 53(4):263-9. PubMed ID: 9069103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
    Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
    Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS].
    Halota W; Jaruga B; Pawłowska M
    Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estimated biological markers of progression in human immunodeficiency virus infection].
    Bélec L; Ripoll L; Matta F; Mbopi Kéou FX; Cotigny S; Longuet MF; Jacob A
    Ann Biol Clin (Paris); 1992; 50(9):621-37. PubMed ID: 1298168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory markers associated with progression of HIV infection.
    Kiepiela P; Smith AN; Rosenberg E
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):243-54. PubMed ID: 15778113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.
    Rouzioux C; Hubert JB; Burgard M; Deveau C; Goujard C; Bary M; Séréni D; Viard JP; Delfraissy JF; Meyer L;
    J Infect Dis; 2005 Jul; 192(1):46-55. PubMed ID: 15942893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Dis Markers; 1990; 8(3):164-5. PubMed ID: 2125538
    [No Abstract]   [Full Text] [Related]  

  • 14. [Virological diagnosis of HIV infection in children].
    Muñoz Fernández MA
    Allergol Immunopathol (Madr); 1998; 26(3):122-9. PubMed ID: 9675394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
    An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neopterin--a prognostic marker in HIV infection].
    Breustedt W; Rabe H; Volk D; Porstmann P
    Dermatol Monatsschr; 1989; 175(4):226-31. PubMed ID: 2499491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.
    Shi M; Taylor JM; Fahey JL; Hoover DR; Muñoz A; Kingsley LA
    J Clin Immunol; 1997 Jan; 17(1):43-52. PubMed ID: 9049785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta2 microglobulin as a surrogate marker for HIV infection: good correlation with CD4 counts.
    Wanchu A; Arora S; Bhatnagar A; Sud A; Bambery P; Singh S
    Indian J Pathol Microbiol; 2004 Apr; 47(2):298-301. PubMed ID: 16295507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes.
    Plaeger S; Bass HZ; Nishanian P; Thomas J; Aziz N; Detels R; King J; Cumberland W; Kemeny M; Fahey JL
    Clin Immunol; 1999 Feb; 90(2):238-46. PubMed ID: 10080836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
    Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
    Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.